Australia's Ansell slips; Morgan Stanley trims PT on tariff impact concerns

ReutersApr 14, 2025 2:58 AM

Medical gloves and surgical gowns maker Ansell ANN.AX falls 1.3% to A$29.33

Morgan Stanley factors in downside risk due to U.S. tariffs, despite ANN expecting to offset impacts through pricing

Lowers PT to A$33.40 from A$37.20; retains 'equal-weight'

Trims revenue growth for co's Industrial and Healthcare units, citing volume risk given slowing macroeconomic growth

Cuts EPS forecast by 9% in FY26 and 11% in FY27; both below Visible Alpha consensus

YTD, ANN down ~13%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

What Are Crypto Stocks? Which Crypto Stocks Are the Best Investments?

As digital capital becomes increasingly enmeshed with global finance, the distinction between "traditional" and "crypto" stocks continues to blur. Whether you seek the aggressive growth of mining companies or the stability of blue-chip tech innovators, crypto stocks offer a flexible, accessible vehi

Musk’s XChat Is Coming to App Store, Meta, Apple and Finance World Are Trembling

Elon Musk’s XChat, the Western equivalent of WeChat, is set to launch on the App Store, issuing a direct challenge to giants such as Meta, Apple, and PayPal.

TSMC vs. Nvidia: Which AI Stock is a Better Investment?

TradingKey - Taiwan Semiconductor Manufacturing (TSMC) has established itself as a crucial player in the Artificial Intelligence (AI) supply chain and this has begun to manifest itself in the performance of TSMC’s shares.

Microsoft Launches Its Own AI Models and Ditches OpenAI Dependence - Is MSFT Stock a Buy at $370?

Microsoft at $370 is a 17%-revenue-growth, 47%-margin, $625-billion-backlog business trading at a multi-year low valuation, because the market is scared of macro noise. The AI model releases this week prove the moat is deepening, not narrowing.

Anthropic IPO 2026: What the Claude Mythos Release Delay Means for Investors and Stock Valuation

Anthropic has delayed the launch of its new AI model, Claude Mythos, projecting a responsible image but potentially weighing on its IPO process.

Featured Tools